THU-356 - Therapeutic Drug Monitoring of DAAs overcomes contraindications against anti-epileptics in HCV treatment (HepNed003)
| Autor: | van Seyen, M., Elise, S.J., Peter, V.W., Drenth, J.P.H., Wouthuyzen-Bakker, M., de Knegt, R., Pieter, H., El Sherif, O., Back, D., Burger, D. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S288-S289 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect